Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Review Article

J Res Educ Indian Med . 2010; 16(1-2): 7-17



Mutrakricchra is one of the common urinary disorders characterised by discomfort
and painful micturition. Eight types of mutrakricchra have been mentioned in Ayurvedic classics
Mutrakricchra can be closely related to the term dysuria which is the leading feature of U.T.I.
Though use of various antibiotics are dealing the problem to some extend, but still even after long
term therapy, the recurrence of infection, development of resistance of microbes along with some
toxic hazards are the reported drawbacks. Recent researches have proved the efficacy of some of
Ayurvedic drugs as diuretic, analgesic, antimicrobial, anti-inflammatory, adaptogenic properties. Still
many of the herbal drugs mentioned in Ayurvedic classics having mutrala (diuretic) property are
yet to be studied. Uptil now only few such compilatory works are available on such drugs and
its rasapanchaka acting in mutravahasrotas. The drugs compiled from different Ayurvedic texts
can be used as a single or can be made into compound formulation, keeping into consideration the
rasapanchaka and their conformed pharmacological activities and doshaja predominance of vyadhi.
214 herbal drugs acting on mutravahasrotas particularly on mutrakricchra have been scrutinized
from various texts. The statistical analysis of rasapanchaka of scrutinized drugs reveals that tikta
rasa is found in maximum i.e 64.5%, followed by madhura, katu and kashaya rasa 42.7% 39.8%
and 32.7% respectively. Among guna, laghu is found maximum i.e. 72.03% ruksha 48.34%,
snigdha and tikshna guna i.e. 38.9% and 28.43% respectively. In virya maximum i.e. 56.9% possess
ushna and shita virya in 40.3%. Regarding vipaka, katu vipaka maximum i.e. 64.9%, whereas
madhura 36.5% has been observed.

Key words: Mutrakricchra, Urinary tract infections, Dysuria, Diuretics, Urinary tract diseases, Analgesic, Anti-microbial.

Similar Articles

Biovalue in Human Brain Banking: Applications and Challenges for Research in Neurodegenerative Diseases.
Vedam-Mai V
Methods in molecular biology (Clifton, N.J.). 2022; 2389(): 209-220

Effects of selenium-containing compounds on Cu/Zn-induced neuronal cell death and potential application as therapeutic agents for neurological diseases.
Tanaka KI, Shimoda M, Kawahara M
Neural regeneration research. 2022; 17(2): 311-312

Striatal oxidative damages and neuroinflammation correlate with progression and survival of Lewy body and Alzheimer diseases.
Li H, Knight WC, Xu J
Neural regeneration research. 2022; 17(4): 867-874

Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects.
Rey F, Ottolenghi S, Zuccotti GV, Samaja M, Carelli S
Neural regeneration research. 2022; 17(4): 754-758

Clinical Performance of Two Automated Immunoassays, EliA CTD Screen and QUANTA Flash CTD Screen Plus, for Antinuclear Antibody Screening.
Yoon S, Moon HW, Kim H, Hur M, Yun YM
Annals of laboratory medicine. 2022; 42(1): 63-70

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites